Results 12,341-12,360 of 28,162 for speaker:Catherine Murphy
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: Why are we skipping over No. 1700B? It is on the list here.
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: I have concerns that this was not-----
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: I have, yes.
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: There are some very large amounts of money involved, the largest is nearly €5 million. Other amounts include €2 million and €1.1 million. I am concerned about how procurement was carried out. Was there just a list of contractors from which people were asked to do the work or was there a robust system? Can we write to the OPW, if we have not done so already-----
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: -----and specifically ask that because I have a concern that did not happen in all cases?
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: Which one is that?
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: A tendering process is one thing, but there are other processes, for example, signing off. Does that fall within our remit? I do not know to which committee it would be more appropriate.
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: It is about the ability to challenge something that has gone wrong and determining whether the process for signing off needs to be challenged. We probably need to understand the situation. I am led to believe that there were people on site who signed off on the project.
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: We do.
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: It would be useful if we had some understanding before it attends.
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: We do not want to get the information on the day and not have time to consider it.
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: All of us have concerns about loans that were in NAMA. People seem to be back in control of assets that they have possibly gained by virtue of getting back into a position without appearing to have the ability to do that. That is the genesis of this. It is a concern for me. People were not supposed to be able to buy back their loans-----
- Public Accounts Committee: Business of Committee (22 Nov 2018)
Catherine Murphy: -----unless they could buy something at par value. It may be anecdotal, but it appears that some people have been able to do this. What kind of follow-through is done by NAMA afterwards? There could be people fronting for other people and things like that.
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018) Catherine Murphy: I remember this well because I was one of the people who got the anti-D and was screened in the 1990s. It was a similar crisis to the one we have had with CervicalCheck. People were very scared. I was one of the lucky ones who got a negative result but some of my contemporaries got positive results and the prognosis was awful at the time. There was worry about contamination. Some people...
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018) Catherine Murphy: Is a profile available in that regard detailing the rate of infection, family members and so on?
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018) Catherine Murphy: It would be useful.
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018) Catherine Murphy: On the drugs that are available, is there any difference in their cost here compared to in other European countries?
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018) Catherine Murphy: Although a small number of people were infected, even relative to our small population, do we have a higher rate of hepatitis C infection than other countries because of the contamination or did such events also happen elsewhere?
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018) Catherine Murphy: Some €1.18 billion went to awards and legal fees. There must have been some learning from the scandal. Was a post-mortem conducted to identify what was handled well and what was not? We have a habit of creating problems or crises in the healthcare system and elsewhere and then resolving them. It is something of a national pastime. We do not always learn from the experiences of the...
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018) Catherine Murphy: The management of medical negligence is part of this discussion. It is very welcome that learnings have been identified. There would be something wrong if they had not. As I stated at the committee last week and on a couple of occasions in the Dáil, some things have not been learned.That women are still seeking copies of their CervicalCheck slides indicates that the system is still...